These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 12544871

  • 1. Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat.
    Jolicoeur EM, Qi S, Xu D, Dumont L, Daloze P, Chen H.
    Transplantation; 2003 Jan 15; 75(1):54-9. PubMed ID: 12544871
    [Abstract] [Full Text] [Related]

  • 2. Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat.
    Vu MD, Qi S, Xu D, Wu J, Peng J, Daloze P, Sehgal S, Leduc B, Chen H.
    Transplantation; 1998 Dec 27; 66(12):1575-80. PubMed ID: 9884242
    [Abstract] [Full Text] [Related]

  • 3. Combined treatment with mycophenolate mofetil and an angiotensin II receptor antagonist fully protects from chronic rejection in a rat model of renal allograft.
    Noris M, Azzollini N, Pezzotta A, Mister M, Benigni A, Marchetti G, Gagliardini E, Perico N, Remuzzi G.
    J Am Soc Nephrol; 2001 Sep 27; 12(9):1937-1946. PubMed ID: 11518788
    [Abstract] [Full Text] [Related]

  • 4. Sirolimus rescue therapy for refractory rejection in renal transplantation.
    Hong JC, Kahan BD.
    Transplantation; 2001 Jun 15; 71(11):1579-84. PubMed ID: 11435968
    [Abstract] [Full Text] [Related]

  • 5. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 15; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 6. Rapamycin is less fibrogenic than Cyclosporin A as demonstrated in a rat model of chronic allograft nephropathy.
    Luo L, Sun Z, Luo G.
    J Surg Res; 2013 Jan 15; 179(1):e255-63. PubMed ID: 22480837
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 2001 Apr 27; 71(8):1091-7. PubMed ID: 11374408
    [Abstract] [Full Text] [Related]

  • 8. Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts.
    Azuma H, Binder J, Heemann U, Schmid C, Tullius SG, Tilney NL.
    Transplantation; 1995 Feb 27; 59(4):460-6. PubMed ID: 7878746
    [Abstract] [Full Text] [Related]

  • 9. Reversal of ongoing heart, kidney, and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin.
    Chen H, Wu J, Xu D, Luo H, Daloze PM.
    Transplantation; 1993 Sep 27; 56(3):661-6. PubMed ID: 8212164
    [Abstract] [Full Text] [Related]

  • 10. Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.
    Kreis H, Cisterne JM, Land W, Wramner L, Squifflet JP, Abramowicz D, Campistol JM, Morales JM, Grinyo JM, Mourad G, Berthoux FC, Brattström C, Lebranchu Y, Vialtel P.
    Transplantation; 2000 Apr 15; 69(7):1252-60. PubMed ID: 10798738
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil and FK506 have different effects on kidney allograft fibrosis in rats that underwent chronic allograft nephropathy.
    Luo L, Sun Z, Wu W, Luo G.
    BMC Nephrol; 2012 Jul 02; 13():53. PubMed ID: 22747784
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
    Sollinger HW.
    Transplantation; 1995 Aug 15; 60(3):225-32. PubMed ID: 7645033
    [Abstract] [Full Text] [Related]

  • 13. Clear benefit of mycophenolate mofetil-based triple therapy in reducing the incidence of acute rejection after living donor renal transplantations.
    Kim YS, Moon JI, Kim SI, Park K.
    Transplantation; 1999 Aug 27; 68(4):578-81. PubMed ID: 10480420
    [Abstract] [Full Text] [Related]

  • 14. Conversion from cyclosporin A to sirolimus retards the progression of chronic allograft nephropathy in the long term in a rat kidney transplantation model.
    He Z, Chen L, Qiu J, Li J, Zhao D, Chen G, Wang C.
    J Int Med Res; 2009 Aug 27; 37(5):1396-410. PubMed ID: 19930844
    [Abstract] [Full Text] [Related]

  • 15. Replacement of mycophenolate mofetil with a JAK inhibitor, AS2553627, in combination with low-dose tacrolimus, for renal allograft rejection in non-human primates.
    Nakamura K, Oshima S, Maeda M, Morio H, Fukahori H, Nakanishi T, Tsujimoto S, Hirose J, Noto T, Hamakawa N, Inami M, Morokata T.
    Int Immunopharmacol; 2018 Nov 27; 64():201-207. PubMed ID: 30195818
    [Abstract] [Full Text] [Related]

  • 16. Successful reversal of acute vascular rejection and cyclosporine-associated nephrotoxicity in renal allograft with combined sirolimus and mycophenolate mofetil as immunotherapy.
    Ołdakowska-Jedynak U, Paczek L, Mucha K, Foroncewicz B, Perkowska-Ptasińska A.
    Transplant Proc; 2006 Nov 27; 38(1):66-8. PubMed ID: 16504666
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil versus Rapamycin in Han: SPRD rats with Polycystic Kidney Disease.
    Zhang T, Wang L, Xiong X, Mao Z, Wang L, Mei C.
    Biol Res; 2009 Nov 27; 42(4):437-44. PubMed ID: 20140299
    [Abstract] [Full Text] [Related]

  • 18. The effect of nutritional immunomodulation on cardiac allograft survival in rats receiving mycophenolate mofetil, cyclosporine A, and donor-specific transfusion.
    Gibson SW, Valente JF, Alexander JW, Custer DA, Babcock GF, Ogle CK.
    J Heart Lung Transplant; 1999 Mar 27; 18(3):185-9. PubMed ID: 10328142
    [Abstract] [Full Text] [Related]

  • 19. Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts.
    Shimizu H, Takahashi M, Takeda S, Inoue S, Fujishiro J, Hakamata Y, Kaneko T, Murakami T, Takeyoshi I, Morishita Y, Kobayashi E.
    Transpl Immunol; 2004 Nov 27; 13(3):219-27. PubMed ID: 15381205
    [Abstract] [Full Text] [Related]

  • 20. Compared to mycophenolate mofetil, rapamycin induces significant changes on growth factors and growth factor receptors in the early days post-kidney transplantation.
    Oliveira JG, Xavier P, Sampaio SM, Henriques C, Tavares I, Mendes AA, Pestana M.
    Transplantation; 2002 Mar 27; 73(6):915-20. PubMed ID: 11923692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.